Trial Profile
Phase I/II Trial of S-1 and Nedaplatin with concurrent radiotherapy in locally advanced mesopharynx, hypopharynx cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Nedaplatin
- Indications Hypopharyngeal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 18 May 2016 New trial record